Ignite Creation Date:
2024-05-06 @ 2:05 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01960634
Status:
COMPLETED
Last Update Posted:
2015-05-05
First Post:
2013-10-07
Brief Title:
Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Sponsor:
Grupo Español Multidisciplinar de Melanoma
Organization:
Grupo Español Multidisciplinar de Melanoma
Study Overview
Official Title:
Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BRAFV600
Brief Summary:
This is a multi-centric translational study with biological samples collection The aim of this study is to validate a method to detect BRAFV600 in blood samples
Samples Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice
The treatment is not the aim of the study Patients can be treated either with specific or no-specific drug
Samples Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice
The treatment is not the aim of the study Patients can be treated either with specific or no-specific drug
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GEM-1304 | OTHER | Sponsor | None |